Paola Defilippi

Full professor

Università degli Studi di Torino

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Paola Defilippi is a Full Professor at Università degli Studi di Torino, Italy. Her research focuses on molecular interactions significant to cancer biology, neurodegenerative diseases, and cell signaling mechanisms, as evidenced by her recent articles on topics such as Alzheimer’s risk factors, breast cancer therapeutic strategies, and immune microenvironment interactions in tumors. Professor Defilippi's work contributes to understanding and developing treatments for various high-risk diseases, including pancreatic adenocarcinoma and melanoma.

Articles (12)

Year:

2025

Year:

2025

Year:

2025

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Miriam Martini

Associate Professor

University of Turin

ITALY

View details

Donatella Valdembri

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

Elena Grassi

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

Eric Lewandowski

University of South Florida

UNITED STATES

View details

Mario Buffelli

Associate professor of physiology

University of Verona

ITALY

View details

Désirée Baruffaldi

Polytechnic University of Turin

ITALY

View details

Chiara Ambrogio

Associate Professor

University of Turin

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paola Defilippi

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

A biophysical and molecular characterization of the interaction between the Alzheimer risk factor BIN1 and the neuronal scaffold protein p140Cap

The Role of Extracellular Vesicles in Mediating Signaling in Biliary Epithelial Cell Activation and Cholangiopathies

A breast cancer PDX collection enriched in luminal (ER+) tumors and young premenopausal patients to identify new therapeutic strategies for high‐risk patients†

Docking protein p130Cas regulates acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis.

The p140Cap adaptor protein as a molecular hub to block cancer aggressiveness

ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3

The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy

Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis

p130Cas/BCAR1 and p140Cap/SRCIN1 Adaptors: The Yin Yang in Breast Cancer?

Correction to: The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma (Cell Death & Differentiation, (2020), 27, 2, (790-807), 10.1038/s41418-019-0386-6)

Molecular Insights into the MAPK Cascade during Viral Infection: Potential Crosstalk between HCQ and HCQ Analogues

The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma

Collaborators (7)

Miriam Martini

Donatella Valdembri

Elena Grassi

Eric Lewandowski

Mario Buffelli

Désirée Baruffaldi

Chiara Ambrogio

Make your next move.

Paola Defilippi

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

A biophysical and molecular characterization of the interaction between the Alzheimer risk factor BIN1 and the neuronal scaffold protein p140Cap

The Role of Extracellular Vesicles in Mediating Signaling in Biliary Epithelial Cell Activation and Cholangiopathies

A breast cancer PDX collection enriched in luminal (ER+) tumors and young premenopausal patients to identify new therapeutic strategies for high‐risk patients†

Docking protein p130Cas regulates acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis.

The p140Cap adaptor protein as a molecular hub to block cancer aggressiveness

ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3

The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy

Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis

p130Cas/BCAR1 and p140Cap/SRCIN1 Adaptors: The Yin Yang in Breast Cancer?

Correction to: The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma (Cell Death &amp; Differentiation, (2020), 27, 2, (790-807), 10.1038/s41418-019-0386-6)

Molecular Insights into the MAPK Cascade during Viral Infection: Potential Crosstalk between HCQ and HCQ Analogues

The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma

Collaborators (7)

Miriam Martini

Donatella Valdembri

Elena Grassi

Eric Lewandowski

Mario Buffelli

Désirée Baruffaldi

Chiara Ambrogio

Make your next move.

Correction to: The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma (Cell Death & Differentiation, (2020), 27, 2, (790-807), 10.1038/s41418-019-0386-6)